Bleeding and Clotting Disorders Institute Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Bleeding and Clotting Disorders Institute's estimated annual revenue is currently $7.3M per year.(i)
  • Bleeding and Clotting Disorders Institute's estimated revenue per employee is $216,000

Employee Data

  • Bleeding and Clotting Disorders Institute has 34 Employees.(i)
  • Bleeding and Clotting Disorders Institute grew their employee count by 21% last year.

Bleeding and Clotting Disorders Institute's People

NameTitleEmail/Phone
1
CEO, Chief Medical Officer and PresidentReveal Email/Phone
2
Director Outreach & Community RelationsReveal Email/Phone
3
Compliance & Grants DirectorReveal Email/Phone
4
Director Human ResourcesReveal Email/Phone
5
Associate Medical & Research Director; Assistant Professor Pediatrics and Medicine - UICOMPReveal Email/Phone
6
Manager Events & EducationReveal Email/Phone
7
Executive AssistantReveal Email/Phone
8
Staff AccountantReveal Email/Phone
9
Nurse CoordinatorReveal Email/Phone
10
Medical Triage AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.3M59-2%N/AN/A
#2
$35.4M1317%N/AN/A
#3
$24.3M9018%N/AN/A
#4
$0.3M2-85%N/AN/A
#5
$33.8M1257%N/AN/A
#6
$7.6M350%N/AN/A
#7
$125.6M372-1%N/AN/A
#8
$5.1M27-7%N/AN/A
#9
$7.8M369%N/AN/A
#10
$8.9M4117%N/AN/A
Add Company

What Is Bleeding and Clotting Disorders Institute?

BCDI is the only federally designated Hemophilia Treatment Center of Excellence in the state of Illinois outside of Chicago. Our team of dedicated professionals serves the entire “downstate” population with over 250 combined years of experience. We specialize in the treatment of adults and children with bleeding, blood clotting, and other non-malignant blood disorders.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$7.3M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A3431%N/A
#2
$5.7M346%N/A
#3
$4.8M346%N/A
#4
$6.2M34-8%N/A
#5
$4.4M343%N/A